BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30766)

  • 1. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L; Schatzberg AF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
    Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
    Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 19. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.